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Aims: Abnormal energy metabolism contributes to heart failure (HF) and the
failing heart is energy starved. Here we tested whether augmented CK energy
metabolism improves myocyte dysfunction in experimental HF.
Methods and Results: We tested the response to the b-agonist isoproterenol
(2.5 nM, ISO) in cardiomyocytes isolated from wild-type (WT) mice and
mice over-expressing cardiac myofibrillar and mitochondrial CK (CK-M
and CK-mito) from sham and HF (8 wk transverse aortic constriction,
TAC) hearts, to dissect whether over-expressing CK-M or CK-mito might
alter myocyte function at baseline or after an increase in energetic demand.
At baseline, there were no differences in sarcomere fractional shortening
(FS) or whole Ca2þ transient amplitude in response to ISO among sham
WT, CK-M or CK-mito myocytes. However, ISO impact on FS, Ca2þ tran-
sient, time to 50 Ca2þ decay, and sarcomere re-lengthening were all reduced
in WT TAC hearts, consistent with prior reports. Conversely, over-expressing
CK-M or CK-mito rescued ISO-induced inotropy in TAC myocytes. No
sizable differences in ISO response were noticed in cells obtained from
sham WT, CK-M or CK-mito hearts. To test whether over-expressing
CK-M or CK-mito confers a degree of protection against acute oxidative
stress, non-TAC myocytes were exposed to H2O2 (50 mM for 10 min). The
interval between the beginning of H2O2 superfusion and the appearance of
an irreversible arrhythmia was measured. WT and CK-M myocytes showed
a similar response (359587s vs. 370560s, n¼5), whereas in CK-mito this
interval was prolonged (580574s).
Conclusions: Over-expressing CK-M and CK-mito under failing-TAC condi-
tions improves myocyte contraction and relaxation, likely through preserved
Ca2þ handling; however, only the up-regulation of CK-mito can effectively
buffer ROS, especially those of mitochondrial origin.
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Cardiac myosin light chain kinase (cMLCK) phosphorylates a single site in the
regulatory light chain (RLC) of myosin to increase Ca2þ sensitivity of myofil-
ament contractions. A constellation of contractile protein phosphorylations in
addition to RLC phosphorylation fine-tune actin-myosin myofibrillar force
development to modulate cardiac performance. In the normal beating heart
RLC is significantly phosphorylated (~45%) which may play a constitutive
physiological role to enhance cardiac performance. Conventional cMLCK
knockout mice have dilated hearts with severely compromised cardiac perfor-
mance at 10 weeks of age and older. To determine if the dilated phenotype
caused by cMLCK knockout is preceded by a loss of cardiac performance
associated with decreased phosphorylation of RLC and other myofibrillar pro-
teins, we generated an acute model for the conditional knockout of cMLCK.
We optimized the minimal amount of tamoxifen necessary for cMLCK ablation
and assessed cardiac performance measured as fractional shortening by echo-
cardiography. Hearts were then harvested for analyses of protein contents
and phosphorylations. Five consecutive daily i.p. injections of 0.5 mg tamox-
ifen per mouse were sufficient to reduce cMLCK 8052% by two weeks after
the first tamoxifen injection. RLC phosphorylation was reduced to 1552%
while left ventricular internal diameter at end-diastole significantly increased
by 1.450.3 mm and fractional shortening decreased 4756%. There was no ev-
idence of compensatory hypertrophy. Troponin-I and myosin binding protein-C
phosphorylation at Ser23/24 and Ser282, respectively, did not significantly
change. Both phosphorylations were reduced with propranolol treatment,
which had no effect on RLC phosphorylation. These results suggest that consti-
tutive RLC phosphorylation contributes to cardiac performance in the normal
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Marfan syndrome (MFS) is a multisystem disorder of connective tissue caused
by mutations in fibrillin-1. Heart involvement in the Marfan syndrome patients
includes aortic root dilatation, valvular insufficiency, and myocardial dys-
function; it remains unclear, however, whether alterations in myocardium are
triggered by valvular and aortic pathology or they develop independently.
We evaluated the age-dependent cardiac remodeling and left ventricular
dysfunction in the mouse model of MFS known as Fbn1039Gþ/mouse (Mar-
fan HT mouse) using echocardiography, pressure-volume loop analyses and a
number of histological and biochemical techniques.
Marfan HT mice of 2-4 month demonstrated a hypertrophic cardiac remodeling
accompanied by predominant decline of diastolic function and increased TGF-b
canonical (p SMAD2/3) and non-canonical (pERK½ and pMAPK38) signaling.
Hypertrophic myocardium among older HT mice (6-14 months) was associated
with two distinctly different phenotypes manifesting either dilated or constricted
LV chamber. Dilatation of LV chamber was accompanied by biochemical evi-
dence of greater mechanical stress, including elevated ERK1/2 phosphorylation
and brain natriuretic peptide expression in comparison with constricted heart.
Diastolic dysfunction in the older HT mice was combined with significant sys-
tolic impairment. The aortic valve regurgitation was registered in 20% of con-
stricted group and 60% of dilated, while mitral insufficiency was observed in
40% of constricted group and 100% of dilated. InMarfan HTmice, extracellular
matrix abnormalities were not associated with the increase of interstitial fibrosis
and non-myocyte proliferation. In the mouse model of fibrillin-1 haploinsuffi-
ciency the early onset of hypertrophic cardiac remodeling and dysfunction is
not consequent to functional valvular abnormalities, but it is likely to result
from deficient mechanosensing and transmission of mechanical forces.
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Carbonic anhydrase III (CAIII) is an abundant protein in skeletal muscle, liver
and adipose cells. A cytosolic enzyme that catalyzes conversions between CO2
and HCO3
- in regulating intracellular pH, its physiological function in muscle is
unclear. Mice lacking CAIII showed lower than wild type intracellular pH in
skeletal muscle cells during fatigue treatment. To further understand the role
of CAIII in muscle functions and stress adaptation, we developed transgenic
mice overexpressing CAIII in the heart under the control of a cloned myosin
heavy chain promoter for phenotype comparisons with wild type mouse hearts
that are CAIII negative. Three months old transgenic mice showed normal car-
diac phenotypes under non-stress conditions. Cardiac function was examined
using ex vivo working heart preparations under normal and low pH conditions
to investigate CAIII function in pH regulation of cardiac muscle. With equili-
bration of 5% CO2 generating pH 7.4 in normal Kreb’s perfusion buffer, 10%
CO2 was used to lower pH to 7.0. Functional data showed that transgenic and
wild type hearts had similar pumping functions under normal pH. Perfused with
low pH buffer, heart functions of both groups were decreased. In comparison
with wild type controls at low pH, CAIII transgenic mouse hearts showed
higher left ventricular pressure development and systolic and diastolic veloc-
ities under both baseline conditions and increased afterload stress, indicating
a better tolerance to acidosis. The results suggest that CAIII may function in
compensating for intracellular pH under acidotic conditions, a tractive novel
approach to develop new treatment of chronic congestive heart failure.
3003-Pos Board B433
Myocardial Interstitial Serotonin and its Major Metabolite, 5-Hydroxyin-
dole Acetic Acid Levels Determined by Microdialysis Technique in vivo
Rat Heart
Cheng-Kun Du, Dong-Yun Zhan, Tsuyoshi Akiyama, Takashi Sonobe,
Tadakatsu Inagaki, Mikiyasu Shirai.
National Cerebral and Cardiovascular Center Research Institute, Osaka, Japan.
Aims: The aim of this study was to elucidate myocardial interstitial serotonin
(5-HT) kinetics in the heart, including 5-HT reuptake and enzymatic degrada-
tion to 5-hydroxyindole acetic acid (5-HIAA) via monoamine oxidase (MAO).
Main methods: Using microdialysis technique in anaesthetized rats, we simulta-
neouslymonitoredmyocardial interstitial levels of 5-HT and its major metabolite,
5-HIAA, in the left ventricle and examined the effects of local administration of a
MAO inhibitor, pargyline, or a 5-HT uptake inhibitor, fluoxetine.
